This rapid test is not intended for outpatients.
It is orderable through the iCentra COVID PowerPlan.
The SARS-CoV-2 / Flu / RSV test is a rapid, multiplexed real-time reverse transcription PCR test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A, Influenza B, and Respiratory Syncytial Virus viral RNA in either nasopharyngeal swab or nasal (mid-turbinate) swab specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2, Influenza, and RSV can be similar. This assay is not intended to detect Influenza C virus.
SARS-CoV-2, Influenza A, Influenza B and RSV RNA identified by this test are generally detectable in upper respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of the identified virus, but do not rule out bacterial infection or co-infection with other pathogens not detected by the test.
Clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. The agent detected may not be the definite cause of disease.

Preferred: Nasopharyngeal swab in viral transport media* (up to 3 mL)
Acceptable, but not preferred:
         Nasal (mid-turbinate) swab in viral transport media* (up to 3 mL)
*VTM, UTM, M4, M4-ART, M5 or M6
Accepted at Primary Children's, Salt Lake, only: Copan Eswab (liquid Amies)
For other sources tested only at Central Lab refer to test code COV19
This assay is not approved for saliva

Nasopharyngeal aspirate or wash
Bronchoalveolar lavage (BAL)
Tracheal aspirate
Sputum
Saliva
Oropharyngeal
Leaking specimens cannot be tested, and will be discarded

Recent exposure to FluMist^® or other live attenuated influenza vaccines may cause inaccurate positive results